Kura Oncology, Inc.

KURANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
8.74 USD
↘ 0.03 (0.34%)AT CLOSE (11:59 AM EDT)
9.45
↗ 0.71 (8.12%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
9.45
↗ 0.71 (8.12%)
🔴Market: CLOSED
Open?$8.76
High?$9.21
Low?$8.56
Prev. Close?$8.77
Volume?3.2M
Avg. Volume?1.8M
VWAP?$8.83
Rel. Volume?1.76x
Bid / Ask
Bid?$8.61 × 2.0K
Ask?$9.30 × 100
Spread?$0.69
Midpoint?$8.96
Valuation & Ratios
Market Cap?775.9M
Shares Out?88.8M
Float?79.9M
Float %?91.9%
P/E Ratio?N/A
P/B Ratio?7.19
EPS?-$3.32
Dividend?0.00%
Ex-Dividend?N/A

Shares of Kura Oncology, Inc. (KURA) are trading at $8.74. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Themes
Healthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
260
Market Cap
775.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.kuraoncology.com
Listed
2015-08-25
Address
4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO, CA 92121
Phone: (858) 500-8800
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
27
Short Sent.?
39
Piotroski F-Score?2/9Weak
Altman Z-Score?-2.36Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?19.57%High
Short Interest?15.6M
Days to Cover?11.4
Free Float79.9M
Avg Daily Volume1.4M
Settlement Date2026-05-15
Financial Health
Current Ratio?6.15Strong
Quick Ratio?6.14Strong
Cash Ratio?0.39Low
Debt/Equity?0.09Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
26
7.19FAIR▾
P/S?
Peers
100
S&P
7
10.83HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.4CHEAP▾
EV/Sales?
Peers
100
S&P
10
10.42HIGH▾
Returns & Efficiency
ROE?
S&P
3
-273.1%WEAK▾
ROA?
S&P
3
-45.1%WEAK▾
Cash Flow & Enterprise
FCF?$-84459000
Enterprise Value?$746.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist